Exo (pronounced Echo) is focused on making point-of-care ultrasound (POCUS) more useful and easier for clinicians to incorporate into patient care with its new Exo Works POCUS workflow solution.
The US Food and Drug Administration cleared the company’s Exo Iris ultrasonic pulsed doppler imaging system in 2021. Exo...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?